ID: ALA56888

Max Phase: Preclinical

Molecular Formula: C18H21NO5

Molecular Weight: 331.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(NC(=O)/C(C)=C/C=C/C(C)=C/C(=O)O)cc(OC)c1

Standard InChI:  InChI=1S/C18H21NO5/c1-12(8-17(20)21)6-5-7-13(2)18(22)19-14-9-15(23-3)11-16(10-14)24-4/h5-11H,1-4H3,(H,19,22)(H,20,21)/b6-5+,12-8+,13-7+

Standard InChI Key:  MEZAHQQCINRTDM-CKSAFXSBSA-N

Associated Targets(Human)

Cellular retinoic acid-binding protein I 14 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoic acid receptor alpha 153 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.37Molecular Weight (Monoisotopic): 331.1420AlogP: 3.18#Rotatable Bonds: 7
Polar Surface Area: 84.86Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.29CX Basic pKa: CX LogP: 2.77CX LogD: -0.20
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.59Np Likeness Score: 0.58

References

1. Shealy YF, Riordan JM, Frye JL, Simpson-Herren L, Sani BP, Hill DL..  (2003)  Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid.,  46  (10): [PMID:12723955] [10.1021/jm020324t]

Source